Therapeutic agent for cancer

This therapeutic agent for cancer contains a compound that acts on a retinoid receptor and a BRAF inhibitor. The therapeutic agent for cancer is for use alongside a BRAF inhibitor, and contains a compound that acts on a retinoid receptor. The compound that acts on a retinoid receptor may be a retino...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Yuya Yoshida, Masanobu Takahashi, Chikashi Ishioka, Sakura Taniguchi
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This therapeutic agent for cancer contains a compound that acts on a retinoid receptor and a BRAF inhibitor. The therapeutic agent for cancer is for use alongside a BRAF inhibitor, and contains a compound that acts on a retinoid receptor. The compound that acts on a retinoid receptor may be a retinoid compound or a derivative thereof. The compound that acts on a retinoid receptor may be ATRA, tamibarotene, or bexarotene. The BRAF inhibitor may be dabrafenib or encorafenib. The therapeutic agent for cancer may further contain an MEK inhibitor. The therapeutic agent for cancer may further contain a compound that acts on an EFG or EGF receptor.